Latham & Watkins represented Inspire in the offering, while Shearman & Sterling advised Goldman Sachs, as sole book-running manager. Inspire Medical Systems, Inc. (NYSE: INSP) executd an...
This content is for Standard 1 Year members only. LoginJoin Now